Welcome to Westonci.ca, the place where your questions are answered by a community of knowledgeable contributors. Get detailed and accurate answers to your questions from a community of experts on our comprehensive Q&A platform. Connect with a community of professionals ready to help you find accurate solutions to your questions quickly and efficiently.
Sagot :
Final answer:
Graft rejection and graft-versus-host disease (GVHD) are rejection processes in organ transplants triggered by the recipient's immune response against donor tissue, involving immune cells targeting foreign cells.
Explanation:
Graft rejection occurs when the recipient's immune system views the transplanted organ or tissue as foreign, triggering an immune response. This rejection process involves the recognition of non-self molecules by the host's dendritic cells, activating cytotoxic T cells that target and kill the grafted cells.
Graft-versus-host disease (GVHD) is a type of rejection where donor T cells from the transplanted tissue attack the recipient's cells, leading to acute GVHD. This is a significant concern in bone marrow transplants due to the immune response mounted by the transplanted tissue.
Major histocompatibility complex markers (MHC I and MHC II), also known as human leukocyte antigens (HLAs), play a crucial role in transplant rejection by triggering the recipient's immune response against the donor tissue.
Learn more about organ transplant rejection here:
https://brainly.com/question/30715235
Thank you for your visit. We're committed to providing you with the best information available. Return anytime for more. We appreciate your time. Please revisit us for more reliable answers to any questions you may have. Your questions are important to us at Westonci.ca. Visit again for expert answers and reliable information.